Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

8.5K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

8.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The physiological relevance of downstream effectors of p53 activity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Clinical Characteristics and Cancer Histories Among Breast Cancer Patients With Li-Fraumeni Syndrome From a Single Institution.

Clinical breast cancer·2026
Same author

Beyond the surface: a collaborative effort for free skin cancer screenings in an underserved community.

BMC public health·2026
Same author

Elucidating cooperative genetic events in DCIS progression in mutant <i>p53</i>-driven breast cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

ODD SPOT: A next generation mnemonic and visual tool for skin cancer education and awareness.

Journal of the American Academy of Dermatology·2026
Same author

Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factors.

NPJ breast cancer·2025
Same journal

Corrigendum: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.

Genes & development·2026
Same journal

A new perspective on ATR's role in translesion synthesis.

Genes & development·2026
Same journal

Mechanisms coordinating exit from the stem cell state in mammals.

Genes & development·2026
Same journal

Evolutionarily conserved spliceosome-exosome pathway in nuclear mRNA surveillance.

Genes & development·2026
Same journal

CDK1 and CEP97 cooperatively control centriole length to orchestrate ciliogenesis and developmental patterning.

Genes & development·2026
Same journal

Coupling of translesion synthesis with the replisome stabilized at stalled replication forks by ATR.

Genes & development·2026
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.6K

Building p53.

Tamara Terzian1, Guillermina Lozano

  • 1Department of Dermatology/Stem Cell Biology, University of Colorado at Denver, Aurora, Colorado 80045, USA.

Genes & Development
|October 19, 2010
PubMed
Summary
This summary is machine-generated.

Researchers discovered a new way the p53 protein is made. A novel RNA-RNA interaction enhances p53 translation after DNA damage, impacting its function.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.9K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.3K

Related Experiment Videos

Last Updated: Dec 24, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.6K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.9K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.3K

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Cancer Research

Background:

  • The tumor suppressor protein p53 is crucial for cellular response to DNA damage.
  • Transcriptional regulation of p53 target genes is well-established.
  • Post-transcriptional and translational control mechanisms for p53 are less understood.

Discussion:

  • Chen and Kastan identified a novel RNA-RNA interaction in the 5' untranslated region (UTR) of p53 mRNA.
  • This interaction is cap-independent and poly(A)-independent, enhancing p53 translation.
  • The mechanism involves binding of the ribosomal protein RPL26 to the p53 mRNA duplex following DNA damage.

Key Insights:

  • A new layer of p53 regulation at the translational level has been uncovered.
  • Disruption of the 5'-3' UTR duplex via oligonucleotides inhibited RPL26 binding.
  • This inhibition led to reduced p53 synthesis and consequently, diminished p53 function.

Outlook:

  • This finding suggests alternative strategies for modulating p53 levels in therapeutic contexts.
  • Further research may explore the broader implications of RNA-RNA interactions in translational control.
  • Understanding this mechanism could offer new avenues for cancer therapy targeting p53.